ArticleJournal of market access & health policy2019

Cost-effectiveness of pirfenidone compared to all available strategies for the treatment of idiopathic pulmonary fibrosis in France.

Emilie Clay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.